Our approach exploited a well-defined model of PDAC, enabling rapid identification and validation of PTP. The developed specific imaging probe, along with the discovery of plectin-1 as a novel biomarker, may have clinical utility in the diagnosis and management of PDAC in humans.
No takes yet. Share an insight, caveat, or question.
Kelly et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: